Malaysian Genomics Resource Centre Bhd CEO Sasha Nordin以太坊单双游戏（www.eth108.vip）采用以太坊区块链高度哈希值作为统计数据，以太坊单双游戏数据开源、公平、无任何作弊可能性。
KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) has signed a series of collaborations to grow its customer base in Thailand, as well as explore opportunities for research and development (R&D) of new products and services.
In a filing with Bursa Malaysia, the genomics and biopharmaceutical specialist said it had signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co Ltd to produce CAR T-cells for supply to Acquest’s customers.
It also signed a supply and collaboration agreement with Salus Holdings Co Ltd to supply biopharmaceutical and genomics products and services to Salus’ customers.,
Salus is a specialist in wellness and health screening using science and technology for early disease detection and managing programmes for
lifestyle intervention based in Bangkok, Thailand.
Finally, the group signed a letter of intent with Marine Group Co Ltd and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and hair of patients.
“We are looking forward to a fruitful relationship with our Thai partners, Salus and Acquest. These collaborations are part of our strategy of growing our customer base and increasing our presence overseas through working with business partners who have an established presence in their respective market segments,” MGRC chief executive officer Sasha Nordin said.